Suppr超能文献

用于测量组织转化的卟吩姆钠荧光评估。

Evaluation of porfimer sodium fluorescence for measuring tissue transformation.

作者信息

Crean D H, Liebow C, Penetrante R B, Mang T S

机构信息

Photodynamic Therapy Center, Roswell Park Cancer Institute, Buffalo, NY 14263.

出版信息

Cancer. 1993 Nov 15;72(10):3068-77. doi: 10.1002/1097-0142(19931115)72:10<3068::aid-cncr2820721032>3.0.co;2-j.

Abstract

BACKGROUND

Neoplastic tissue can be detected by its increased fluorescence compared with surrounding normal tissue after the injection of the tumor-localizing compound porfimer sodium (Photofrin; Quadra Logic Technologies, Vancouver, BC, Canada). In vivo fluorescence photometry is a nonimaging photodetector technique that detects specific 690 nm fluorescence of the porphyrin by subtracting nonspecific 612 nm excitation from 630 nm excitation. The technique was applied in the developmental stages of the 9,10 dimethyl-1,2-benzanthracene (DMBA)-induced hamster buccal cheek pouch carcinoma model to (1) quantitate and characterize porfimer sodium fluorescence and uptake as it relates to lesion progression and biochemical changes and (2) determine whether porfimer sodium-induced fluorescence will vary with promotional and inhibitory stimuli.

METHODS

Groups of Syrian Golden hamsters had their cheek pouch buccal mucosa exposed to a 0.5% DMBA in acetone three times per week for 6 weeks (premalignant lesions), 12 weeks (squamous cell carcinomas), or other specified durations. The rate of malignant transformation was either promoted (by either carbon dioxide laser incision or continued DMBA application) or inhibited (by the administration of either somatostatin analogue RC-160 [D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2] or bombesin antagonist RC-3095 [D-Tpi-Gln-Trp-Ala-Val-Gly-His-Leu psi (CH2NH)Leu-NH2]). Groups of DMBA-exposed hamsters were subsequently injected with 1.0 mg/kg of porfimer sodium during the various stages of tumor development. Twenty-four hours after injection, fluorescence levels were measured by in vivo fluorescence photometry. Samples of tumors, dysplastic mucosal tissue, and normal-appearing oral mucosa were biopsied and used for either tissue extraction assays, histopathologic examination, or tyrosine kinase activity assay as an index of rate of transformation.

RESULTS

Results demonstrated that porfimer sodium is retained in DMBA-treated tissue. Fluorescence is completely accounted for by porfimer sodium uptake. The duration of exposure to carcinogen is proportional to porfimer sodium fluorescence. This relationship establishes that premalignant lesions can be distinguished from normal tissue by porfimer sodium uptake and fluorescence. The changes in increased tyrosine kinase activity paralleled the increase in porfimer sodium fluorescence. Alterations in the rate of tissue transformation produced equivalent alterations in porfimer sodium-induced fluorescence.

CONCLUSIONS

These results suggest that porfimer sodium uptake and fluorescence can be used in a prognostic manner to diagnose and determine the course of transformation of individual lesions.

摘要

背景

注射肿瘤定位化合物卟吩姆钠(光卟啉;Quadra Logic Technologies公司,加拿大不列颠哥伦比亚省温哥华)后,肿瘤组织相较于周围正常组织会出现荧光增强,借此可检测肿瘤组织。体内荧光光度法是一种非成像光检测技术,通过从630nm激发光中减去非特异性612nm激发光来检测卟啉特定的690nm荧光。该技术应用于9,10 - 二甲基 - 1,2 - 苯并蒽(DMBA)诱导的仓鼠颊囊癌模型的发育阶段,以(1)定量和表征卟吩姆钠荧光及摄取情况,及其与病变进展和生化变化的关系,(2)确定卟吩姆钠诱导的荧光是否会因促癌和抑癌刺激而变化。

方法

叙利亚金黄仓鼠分组,其颊囊颊黏膜每周3次暴露于含0.5% DMBA的丙酮中,持续6周(癌前病变)、12周(鳞状细胞癌)或其他特定时长。恶性转化速率通过促癌(二氧化碳激光切割或持续应用DMBA)或抑癌(给予生长抑素类似物RC - 160 [D - 苯丙氨酸 - 半胱氨酸 - 酪氨酸 - D - 色氨酸 - 赖氨酸 - 缬氨酸 - 和胱氨酸 - 色氨酸 - NH2]或蛙皮素拮抗剂RC - 3095 [D - 噻吩丙氨酸 - 谷氨酰胺 - 色氨酸 -丙氨酸 -缬氨酸 -甘氨酸 -组氨酸 -亮氨酸ψ(CH2NH)亮氨酸 - NH2])来改变。在肿瘤发展的不同阶段,给暴露于DMBA的仓鼠组注射1.0mg/kg的卟吩姆钠。注射24小时后,通过体内荧光光度法测量荧光水平。对肿瘤、发育异常的黏膜组织和外观正常的口腔黏膜样本进行活检,用于组织提取分析、组织病理学检查或酪氨酸激酶活性测定,作为转化速率的指标。

结果

结果表明卟吩姆钠保留在DMBA处理的组织中。荧光完全由卟吩姆钠摄取引起。致癌物暴露时长与卟吩姆钠荧光成正比。这种关系表明癌前病变可通过卟吩姆钠摄取和荧光与正常组织区分开来。酪氨酸激酶活性增加的变化与卟吩姆钠荧光增加平行。组织转化速率的改变在卟吩姆钠诱导的荧光中产生同等改变。

结论

这些结果表明,卟吩姆钠摄取和荧光可用于以预后方式诊断和确定个体病变的转化过程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验